amiodarone has been researched along with Mitral Valve Stenosis in 7 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Mitral Valve Stenosis: Narrowing of the passage through the MITRAL VALVE due to FIBROSIS, and CALCINOSIS in the leaflets and chordal areas. This elevates the left atrial pressure which, in turn, raises pulmonary venous and capillary pressure leading to bouts of DYSPNEA and TACHYCARDIA during physical exertion. RHEUMATIC FEVER is its primary cause.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Amiodarone, used in conjunction with percutaneous balloon mitral commissurotomy, can safely convert rheumatic atrial fibrillation in 38% of patients compared with 0% in those without it." | 9.10 | Conversion of rheumatic atrial fibrillation by amiodarone after percutaneous balloon mitral commissurotomy. ( Hsueh, CW; Lai, HC; Lee, WL; Liu, TJ; Ting, CT; Wang, KY, 2003) |
| "Low-dose amiodarone was safe and effective in restoring and maintaining SR in patients with AF and rheumatic heart disease." | 7.71 | Management of persistent atrial fibrillation following balloon mitral valvotomy: safety and efficacy of low-dose amiodarone. ( Kapoor, A; Kumar, S; Pandey, CM; Singh, RK; Sinha, N, 2002) |
| "Amiodarone, used in conjunction with percutaneous balloon mitral commissurotomy, can safely convert rheumatic atrial fibrillation in 38% of patients compared with 0% in those without it." | 5.10 | Conversion of rheumatic atrial fibrillation by amiodarone after percutaneous balloon mitral commissurotomy. ( Hsueh, CW; Lai, HC; Lee, WL; Liu, TJ; Ting, CT; Wang, KY, 2003) |
| "Low-dose amiodarone was safe and effective in restoring and maintaining SR in patients with AF and rheumatic heart disease." | 3.71 | Management of persistent atrial fibrillation following balloon mitral valvotomy: safety and efficacy of low-dose amiodarone. ( Kapoor, A; Kumar, S; Pandey, CM; Singh, RK; Sinha, N, 2002) |
| "Amiodarone 200 mg/day was started the day after PBMV." | 2.72 | One-year outcome of cardioversion of atrial fibrillation in patients with mitral stenosis after percutaneous balloon mitral valvuloplasty. ( Chotinaiwatarakul, C; Jakrapanichakul, D; Kangkagate, C; Kitrattana, B; Krittayaphong, R; Panchavinnin, P; Phankingthongkum, R; Sriratanasathavorn, C; Tresukosol, D, 2006) |
| "The amiodarone dosage was lowered to 200 mg/day in the sixth postoperative week." | 2.71 | Effects of late regain of sinus rhythm on pulmonary artery pressure and functional status in patients with mitral valve replacement surgery and atrial fibrillation. ( Demircioglu, F; Ersel, F; Gölbasi, I; Kabukcu, M; Yanik, E, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maheshwari, M | 1 |
| Mittal, SR | 1 |
| Moreau, C | 1 |
| Bajolle, F | 1 |
| Siguret, V | 1 |
| Loriot, MA | 1 |
| Bonnet, D | 1 |
| Kapoor, A | 1 |
| Kumar, S | 1 |
| Singh, RK | 1 |
| Pandey, CM | 1 |
| Sinha, N | 1 |
| Liu, TJ | 1 |
| Hsueh, CW | 1 |
| Lee, WL | 1 |
| Lai, HC | 1 |
| Wang, KY | 1 |
| Ting, CT | 1 |
| Nogami, A | 1 |
| Tada, H | 1 |
| Naito, S | 1 |
| Kaneko, T | 1 |
| Kabukcu, M | 1 |
| Yanik, E | 1 |
| Demircioglu, F | 1 |
| Gölbasi, I | 1 |
| Ersel, F | 1 |
| Krittayaphong, R | 1 |
| Chotinaiwatarakul, C | 1 |
| Phankingthongkum, R | 1 |
| Panchavinnin, P | 1 |
| Tresukosol, D | 1 |
| Jakrapanichakul, D | 1 |
| Sriratanasathavorn, C | 1 |
| Kitrattana, B | 1 |
| Kangkagate, C | 1 |
3 trials available for amiodarone and Mitral Valve Stenosis
| Article | Year |
|---|---|
Conversion of rheumatic atrial fibrillation by amiodarone after percutaneous balloon mitral commissurotomy.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheterization; Combined Modality Therapy; | 2003 |
Effects of late regain of sinus rhythm on pulmonary artery pressure and functional status in patients with mitral valve replacement surgery and atrial fibrillation.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Echocardiography, Doppler; Electric | 2004 |
One-year outcome of cardioversion of atrial fibrillation in patients with mitral stenosis after percutaneous balloon mitral valvuloplasty.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheterization; Electric Countersho | 2006 |
4 other studies available for amiodarone and Mitral Valve Stenosis
| Article | Year |
|---|---|
Wolff-Parkinson-White syndrome and rheumatic mitral stenosis--an uncommon association.
Topics: Amiodarone; Anti-Arrhythmia Agents; Anticoagulants; Diuretics; Electrocardiography; Humans; Male; Mi | 2010 |
Genetic resistance to warfarin therapy masked by amiodarone in a 2-year-old girl with mitral valve replacement.
Topics: Amiodarone; Anti-Arrhythmia Agents; Anticoagulants; Blood Coagulation; Child, Preschool; Chromatogra | 2013 |
Management of persistent atrial fibrillation following balloon mitral valvotomy: safety and efficacy of low-dose amiodarone.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheterization; Combined Modality T | 2002 |
Unidirectional atrio-atrial conduction after surgical isolation of the posterior part of the left atrium and pulmonary veins for atrial fibrillation: simple postsurgical procedure electrophysiological evaluation.
Topics: Adenosine Triphosphate; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cryosurgery; | 2004 |